Copyright
©The Author(s) 2017.
World J Gastrointest Surg. Apr 27, 2017; 9(4): 97-102
Published online Apr 27, 2017. doi: 10.4240/wjgs.v9.i4.97
Published online Apr 27, 2017. doi: 10.4240/wjgs.v9.i4.97
Demographics (%) | |
Gender | |
Male | 62 |
Female | 38 |
Age | |
< 50 | 18 |
51-70 | 54 |
> 70 | 28 |
Race | |
Caucasian | 88 |
African American | 8 |
Other | 4 |
Insurance | 50 |
Private | 43 |
Medicare/Medicaid | |
None | 4 |
Other | 3 |
Unknown staging | % |
Overall unknown | |
Path stage | 25 |
Clinical stage | 21 |
Both stages | 5 |
Academic unknown | |
Path stage | 24 |
Clinical stage | 17 |
Both stages | 5 |
Community unknown | |
Path stage | 26 |
Clinical stage | 23 |
Both stages | 6 |
Unknown staging | % |
Overall | |
Up-stage | 8 |
Down-stage | 17 |
No change | 24 |
Academic | |
Up-stage | 8 |
Down-stage | 20 |
No change | 26 |
Community | |
Up-stage | 8 |
Down-stage | 15 |
No change | 23 |
- Citation: Reddy SS, Handorf B, Farma JM, Sigurdson ER. Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies. World J Gastrointest Surg 2017; 9(4): 97-102
- URL: https://www.wjgnet.com/1948-9366/full/v9/i4/97.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v9.i4.97